Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $727.9300 (0.38%) ($727.9300 - $729.3600) on Tue. May. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 34 | Latest Price | $727.9300(0.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(45%) DIA(31%) SPLV(29%) VYM(28%) | Factors Impacting REGN price | REGN will decline at least -0.785% in a week (0% probabilities). VXX(-24%) VIXM(-19%) TBT(-5%) ACES(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $750.48 | 5 Day Moving Average | $732.94(-0.68%) | 10 Day Moving Average | $740.98(-1.76%) | 20 Day Moving Average | $750.48(-3%) | To recent high | -12.3% | To recent low | 0.4% | Market Cap | $77.181b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |